Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mongan, Nigel P"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 26
Tytuł:
The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.
Autorzy:
Lashen A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Department of Pathology, Nottingham University Hospital, City Campus, Nottingham NG5 1PB, UK.
Algethami M; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Alqahtani S; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Shoqafi A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Sheha A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Jeyapalan JN; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Faculty of Medicine and Health Sciences, Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.
Mongan NP; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Faculty of Medicine and Health Sciences, Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Rakha EA; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Madhusudan S; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 05; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Retinoblastoma*
Ovarian Neoplasms*/genetics
Retinal Neoplasms*
Female ; Humans ; Carcinoma, Ovarian Epithelial ; Cyclin D1/genetics ; Cyclin-Dependent Kinase 2/genetics ; Ubiquitin-Protein Ligases ; Retinoblastoma Binding Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.
Autorzy:
Kurozumi S; Department of Breast Surgery, International University of Health and Welfare, Chiba 286-8520, Japan.; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Seki N; Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Narusawa E; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Honda C; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Tokuda S; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Nakazawa Y; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Yokobori T; Initiative for Advanced Research, Gunma University, Gunma 371-8511, Japan.
Katayama A; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Mongan NP; Biodiscovery Institute, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Rakha EA; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.; Pathology Department, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Oyama T; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Fujii T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
Horiguchi J; Department of Breast Surgery, International University of Health and Welfare, Chiba 286-8520, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 19; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
Breast Neoplasms*/genetics
Humans ; Female ; Breast ; Cluster Analysis ; Computational Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.
Autorzy:
Alblihy A; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Ali R; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Algethami M; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Ritchie AA; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Shoqafi A; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Alqahtani S; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Mesquita KA; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Toss MS; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Ordóñez-Morán P; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Jeyapalan JN; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.; Faculty of Medicine and Health Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.
Dekker L; Nottingham Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham NG7 3RD, UK.
Salerno M; North West Cancer Research Institute, School of Medical and Health Sciences, Bangor University, Bangor LL57 2UW, UK.
Hartsuiker E; North West Cancer Research Institute, School of Medical and Health Sciences, Bangor University, Bangor LL57 2UW, UK.
Grabowska AM; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Rakha EA; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.; Department of Pathology, Nottingham University Hospitals, City Campus, Nottingham NG5 1PB, UK.
Mongan NP; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.
Madhusudan S; Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 30; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
DNA-Binding Proteins*/metabolism
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Humans ; Female ; MRE11 Homologue Protein/genetics ; MRE11 Homologue Protein/metabolism ; HeLa Cells ; Precision Medicine ; BRCA2 Protein/metabolism ; DNA Repair ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of COVID-19 on student attainment and pedagogical needs when undertaking independent scientific research.
Autorzy:
Jeyapalan JN; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
James V; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
Gardner DS; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
Lothion-Roy JH; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
Mongan NP; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
Rutland CS; School of Veterinary Medicine and Science, Medical Faculty, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Anatomia, histologia, embryologia [Anat Histol Embryol] 2023 Jan; Vol. 52 (1), pp. 93-100. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:
Journal Article
MeSH Terms:
Pandemics*
COVID-19*/epidemiology
COVID-19*/veterinary
Animals ; Humans ; Students
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Refining the definition of HER2-low class in invasive breast cancer.
Autorzy:
Atallah NM; Department of Histopathology, School of Medicine, the University of Nottingham and Nottingham University, Hospitals NHS Trust, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt.; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Toss MS; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.; Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Green AR; Division of Cancer and Stem Cells, Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham, UK.
Mongan NP; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington, UK.
Ball G; Division of Life Sciences, Nottingham Trent University, Nottingham, UK.
Rakha EA; Department of Histopathology, School of Medicine, the University of Nottingham and Nottingham University, Hospitals NHS Trust, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 770-785. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Immunoconjugates*
Humans ; Female ; Receptor, ErbB-2/analysis ; Immunohistochemistry ; Reproducibility of Results ; In Situ Hybridization, Fluorescence ; RNA, Messenger
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods.
Autorzy:
Lashen A; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.; Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.
Toss MS; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.; Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, UK.
Green AR; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.
Mongan NP; School of Veterinary Medicine and Sciences, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, USA.
Rakha E; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.; Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Dec; Vol. 81 (6), pp. 786-798. Date of Electronic Publication: 2022 Sep 19.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Female ; Humans ; Ki-67 Antigen/metabolism ; Prognosis ; Reproducibility of Results ; Research Design
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
Autorzy:
Kariri YA; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Department of Clinical Laboratory Science, Faculty of Applied Medical Science, Shaqra University, Shaqra 11961, Saudi Arabia.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.
Joseph C; School of Medicine, Nottingham City Hospital, Nottingham University Hospitals NHS Trust and The University of Nottingham, Nottingham NG5 1PB, UK.
Alsaleem MA; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.; Department of Applied Medical Science, Applied College, Qassim University, Unayzah 56435, Saudi Arabia.
Elsharawy KA; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.; Department of Zoology, Faculty of Science, Damietta University, Damietta 34517, Egypt.
Alsaeed S; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.; Department of Clinical Laboratory Science, Faculty of Applied Medical Sciences, Northern Border University, Arar 73244, Saudi Arabia.
Toss MS; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.; School of Medicine, Nottingham City Hospital, Nottingham University Hospitals NHS Trust and The University of Nottingham, Nottingham NG5 1PB, UK.
Mongan NP; Biodiscovery Institute, Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG7 2RD, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Green AR; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.
Rakha EA; Academic Unit for Translational Medical Sciences, School of Medicine, Biodiscovery Institute, University Park Campus, University of Nottingham, Nottingham NG7 2RD, UK.; Nottingham Breast Cancer Research Centre, Nottingham NG7 2RD, UK.; School of Medicine, Nottingham City Hospital, Nottingham University Hospitals NHS Trust and The University of Nottingham, Nottingham NG5 1PB, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Nov 17; Vol. 14 (22). Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.
Autorzy:
Haigh DB; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Woodcock CL; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Lothion-Roy J; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Harris AE; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Metzler VM; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Persson JL; Department of Molecular Biology, Umeå University, 901 87 Umeå, Sweden.; Department of Biomedical Sciences, Malmö Universitet, 202 04 Malmö, Sweden.
Robinson BD; Department of Pathology, Weill Cornell Medicine, New York, NY 10065, USA.
Khani F; Department of Pathology, Weill Cornell Medicine, New York, NY 10065, USA.
Alsaleem M; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.; Department of Applied Medical Science, Applied College, Qassim University, Unayzah 51911, Qassim, Saudi Arabia.
Ntekim A; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.; Department of Radiation Oncology, University College Hospital, University of Ibadan, Ibadan 200132, Nigeria.
Madhusudan S; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Davis MB; Department of Surgery, Weill Cornell Medicine, New York, NY 10065, USA.
Laursen KB; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Gudas LJ; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Rutland CS; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Toss MS; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Archer N; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Bodi Z; School of Biosciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Rakha EA; School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.
Fray RG; School of Biosciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Jeyapalan JN; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.
Mongan NP; Biodiscovery Institute, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Sutton Bonington LE12 5RD, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 20; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
Autorzy:
de Brot S; COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.; School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Lothion-Roy J; School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.; BioDiscovery Institute, University of Nottingham, Nottingham, UK.
Grau-Roma L; COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.
White E; School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Guscetti F; Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland.
Rubin MA; Department of BioMedical Research, University of Bern, Bern, Switzerland.; Bern Center for Precision Medicine, University of Bern and Inselspital, Bern, Switzerland.
Mongan NP; BioDiscovery Institute, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, New York, USA.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2022 Mar; Vol. 20 (1), pp. 38-49. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Intraductal, Noninfiltrating*/metabolism
Carcinoma, Intraductal, Noninfiltrating*/pathology
Carcinoma, Intraductal, Noninfiltrating*/veterinary
Carcinoma, Transitional Cell*/metabolism
Carcinoma, Transitional Cell*/veterinary
Dog Diseases*/pathology
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms*/veterinary
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/veterinary
Animals ; Biomarkers, Tumor/metabolism ; Dogs ; Immunohistochemistry ; Male ; Prostate/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.
Autorzy:
Kurozumi S; Department of Breast Surgery, International University of Health and Welfare, 852, Hatakeda, Narita, Chiba, 286-8520, Japan. .; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan. .
Kaira K; Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan.
Matsumoto H; Division of Breast Surgery, Saitama Cancer Center, Saitama, Japan.
Kurosumi M; Department of Pathology, Saitama Cancer Center, Saitama, Japan.
Yokobori T; Gunma University Initiative for Advanced Research (GIAR), Maebashi, Gunma, Japan.
Kanai Y; Division of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Sekine C; Department of Breast Surgery, International University of Health and Welfare, 852, Hatakeda, Narita, Chiba, 286-8520, Japan.
Honda C; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
Katayama A; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
Furuya M; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
Shiino S; Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Makiguchi T; Department of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Gunma, Japan.
Mongan NP; Biodiscovery Institute, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Rakha EA; Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Oyama T; Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
Fujii T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
Horiguchi J; Department of Breast Surgery, International University of Health and Welfare, 852, Hatakeda, Narita, Chiba, 286-8520, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Feb 17; Vol. 12 (1), pp. 2742. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/immunology
Breast Neoplasms*/mortality
Breast Neoplasms*/pathology
Large Neutral Amino Acid-Transporter 1/*immunology
Adult ; Aged ; B7-H1 Antigen/immunology ; Disease-Free Survival ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Receptor, ErbB-2/metabolism ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative pathology of dog and human prostate cancer.
Autorzy:
Ryman-Tubb T; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Lothion-Roy JH; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Metzler VM; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Harris AE; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Robinson BD; Department of Pathology, Weill Cornell Medicine, NY, New York, USA.
Rizvanov AA; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.; Institute of Fundamental Medicine and Science, Kazan Federal University, Kazan, Tatarstan, Russia.
Jeyapalan JN; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
James VH; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
England G; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Rutland CS; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Persson JL; Department of Molecular Biology, Umeå Universitet, Umeå, Sweden.; Department of Biomedical Sciences, Malmö Universitet, Malmö, Sweden.
Kenner L; Department of Experimental Pathology, Laboratory Animal Pathology Medical University Wien, Vienna, Austria.
Rubin MA; Bern Center for Precision Medicine, University of Bern and Inselspital, Bern, Switzerland.; Department of BioMedical Research, University of Bern and Inselspital, Bern, Switzerland.
Mongan NP; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, New York, USA.
de Brot S; BioDiscovery Institute, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.; COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2022 Jan; Vol. 8 (1), pp. 110-120. Date of Electronic Publication: 2021 Oct 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Dog Diseases*/drug therapy
Dog Diseases*/epidemiology
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/pathology
Prostatic Neoplasms, Castration-Resistant*/veterinary
Androgen Antagonists/therapeutic use ; Animals ; Dogs ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
Autorzy:
Lashen AG; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
Toss MS; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
Katayama A; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebaashi, Japan.
Gogna R; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
Mongan NP; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.; School of Veterinary Medicine and Sciences, University of Nottingham, Nottingham, UK.
Rakha EA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 Dec; Vol. 79 (6), pp. 1087-1098. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Cell Cycle*
Cell Proliferation*
Mitosis*
Breast Neoplasms/*pathology
Adult ; Aged ; Female ; Humans ; Middle Aged ; Mitotic Index ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
Autorzy:
Joseph C; School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham NG7 2RD, UK.
Alsaleem MA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.; Department of Applied Medical Sciences, Unayzah Community College, Qassim University, Unayzah 56435, Saudi Arabia.
Toss MS; School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham NG7 2RD, UK.; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Kariri YA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.; Department of Clinical Laboratory Science, Faculty of Applied Medical Science, Shaqra University 33, Shaqra 11961, Saudi Arabia.
Althobiti M; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.; Department of Clinical Laboratory Science, Faculty of Applied Medical Science, Shaqra University 33, Shaqra 11961, Saudi Arabia.
Alsaeed S; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Aljohani AI; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Narasimha PL; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Mongan NP; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Rakha EA; School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham NG7 2RD, UK.; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham NG7 2RD, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Dec 30; Vol. 13 (1). Date of Electronic Publication: 2020 Dec 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study.
Autorzy:
Rakha EA; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Alsaleem M; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
ElSharawy KA; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Toss MS; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Raafat S; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Mihai R; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Minhas FA; Department of Computer Science, University of Warwick, Coventry, UK.
Green AR; School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Rajpoot NM; Department of Computer Science, University of Warwick, Coventry, UK.
Dalton LW; Department of Histopathology, South Austin Hospital, Austin, TX, USA.
Mongan NP; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, University of Nottingham Biodiscovery Institute, Nottingham, UK.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2020 Oct; Vol. 77 (4), pp. 631-645. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Cytodiagnosis/methods ; Female ; Gene Expression Profiling/methods ; Humans ; Transcriptome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds.
Autorzy:
Simpson S; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Dunning M; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Willows Veterinary Centre and Referral Service, Solihull B90 4NH, UK.
de Brot S; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; COMPATH, Institute of Animal Pathology, University of Bern, Laenggassstrasse 122, CH-3012 Bern, Switzerland.
Alibhai A; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Bailey C; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Woodcock CL; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Biodiscovery Institute, Faculty of Medicine and Health Science, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Mestas M; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Akhtar S; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Jeyapalan JN; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Biodiscovery Institute, Faculty of Medicine and Health Science, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Lothion-Roy J; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Biodiscovery Institute, Faculty of Medicine and Health Science, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Emes RD; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Allegrucci C; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Biodiscovery Institute, Faculty of Medicine and Health Science, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Rizvanov AA; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 42008, Russia.
Mongan NP; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.; Biodiscovery Institute, Faculty of Medicine and Health Science, University of Nottingham, University Park, Nottingham NG7 2RD, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Rutland CS; School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Aug 25; Vol. 12 (9). Date of Electronic Publication: 2020 Aug 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer.
Autorzy:
Shafiee MN; Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
Ortori CA; Division of Advanced Materials and Healthcare Technologies School of Pharmacy, Centre for Analytical Bioscience, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Barrett DA; Division of Advanced Materials and Healthcare Technologies School of Pharmacy, Centre for Analytical Bioscience, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Mongan NP; University of Nottingham Biodiscovery Institute, University of Nottingham LE12 5RD, UK.; School of Veterinary Medicine and Science, University of Nottingham LE12 5RD, UK.
Abu J; Department of Obstetrics and Gynaecology, City Hospital, Nottingham University Hospital, Nottingham NG5 1PB, UK.
Atiomo W; Division of Obstetrics and Gynaecology and Child Health, School of Medicine, Faculty of Medicine and Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham University Hospital, Derby Road, Nottingham NG7 2UH, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Jul 03; Vol. 21 (13). Date of Electronic Publication: 2020 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Lipid Metabolism*
Endometrial Neoplasms/*metabolism
Polycystic Ovary Syndrome/*metabolism
Adult ; Aged ; Biomarkers/metabolism ; Biomarkers, Tumor/metabolism ; Case-Control Studies ; Cross-Sectional Studies ; Decanoic Acids/metabolism ; Endometrial Neoplasms/etiology ; Female ; Humans ; Lipidomics ; Middle Aged ; Monoglycerides/metabolism ; Multivariate Analysis ; Polycystic Ovary Syndrome/complications
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Autorzy:
Orfali N; Cork Cancer Research Centre & CancerResearch@UCC, Western Gateway Building, University College Cork, Cork, Ireland.; Department of Haematology, Cork University Hospital, Cork, Ireland.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
O'Donovan TR; Cork Cancer Research Centre & CancerResearch@UCC, Western Gateway Building, University College Cork, Cork, Ireland.
Cahill MR; Cork Cancer Research Centre & CancerResearch@UCC, Western Gateway Building, University College Cork, Cork, Ireland.; Department of Haematology, Cork University Hospital, Cork, Ireland.
Benjamin D; Cork Cancer Research Centre & CancerResearch@UCC, Western Gateway Building, University College Cork, Cork, Ireland.; Department of Haematology, Cork University Hospital, Cork, Ireland.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Nanus DM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
McKenna SL; Cork Cancer Research Centre & CancerResearch@UCC, Western Gateway Building, University College Cork, Cork, Ireland.
Gudas LJ; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Mongan NP; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; University of Nottingham Biodiscovery Institute, Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2020 Mar; Vol. 104 (3), pp. 236-250. Date of Electronic Publication: 2020 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/*genetics
Cell Differentiation/*drug effects
Gene Expression Regulation, Leukemic/*drug effects
Leukemia, Promyelocytic, Acute/*genetics
Leukemia, Promyelocytic, Acute/*pathology
Tretinoin/*pharmacology
Antineoplastic Agents/therapeutic use ; Autophagy/genetics ; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism ; Biopsy ; Bone Marrow/pathology ; Cell Line, Tumor ; Gene Knockdown Techniques ; Humans ; Leukemia, Promyelocytic, Acute/drug therapy ; Leukemia, Promyelocytic, Acute/metabolism ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; RNA Interference ; RNA, Small Interfering/genetics ; Signal Transduction/drug effects ; Tretinoin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of breast cancer grade discordance on prediction of outcome.
Autorzy:
Rakha EA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.; Faculty of Medicine, Menoufyia University, Shebin Elkom, Egypt.
Aleskandarany MA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.; Faculty of Medicine, Menoufyia University, Shebin Elkom, Egypt.
Toss MS; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Mongan NP; Faculty of Medicine and Health Sciences, University of Nottingham, Leicestershire, UK.
ElSayed ME; Faculty of Medicine, Menoufyia University, Shebin Elkom, Egypt.
Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Ellis IO; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.
Dalton LW; Department of Histopathology, South Austin Hospital, Austin, TX, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2018 Dec; Vol. 73 (6), pp. 904-915. Date of Electronic Publication: 2018 Sep 19.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms/*pathology
Lymphatic Metastasis/*pathology
Breast Neoplasms/mortality ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Neoplasm Grading ; Prognosis ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology.
Autorzy:
de Brot S; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Robinson BD; Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA.
Scase T; Bridge Pathology Ltd., Bristol, BS7 0BJ, UK.
Grau-Roma L; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Wilkinson E; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
Gardner D; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Mongan NP; School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, LE12 5RD, UK.; Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2018 Aug; Vol. 16 (2), pp. 1641-1649. Date of Electronic Publication: 2018 May 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.
Autorzy:
Krejsgaard T; Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3c, DK-2200, Copenhagen N, Denmark. .
Lindahl LM; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Mongan NP; School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK.
Wasik MA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Litvinov IV; Division of Dermatology, University of Ottawa, Ottawa, ON, Canada.
Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Langhoff E; James J. Peters VA Medical Center, Veterans Affairs, Bronx, NY, USA.
Woetmann A; Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3c, DK-2200, Copenhagen N, Denmark.
Odum N; Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3c, DK-2200, Copenhagen N, Denmark. .
Pokaż więcej
Źródło:
Seminars in immunopathology [Semin Immunopathol] 2017 Apr; Vol. 39 (3), pp. 269-282. Date of Electronic Publication: 2016 Oct 07.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammation/*immunology
Inflammation/*metabolism
Lymphoma, T-Cell, Cutaneous/*etiology
Lymphoma, T-Cell, Cutaneous/*metabolism
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
Animals ; Cell Communication/genetics ; Cell Communication/immunology ; Cell Movement/immunology ; Cytokines/metabolism ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Humans ; Immunity, Cellular/drug effects ; Immunity, Cellular/immunology ; Immunity, Innate ; Inflammation/complications ; Inflammation/pathology ; Lymphoma, T-Cell, Cutaneous/drug therapy ; Lymphoma, T-Cell, Cutaneous/pathology ; Signal Transduction ; Stromal Cells/metabolism ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Th2 Cells/immunology ; Th2 Cells/metabolism ; Tumor Microenvironment/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 26

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies